Page last updated: 2024-10-31

mirtazapine and Migraine Disorders

mirtazapine has been researched along with Migraine Disorders in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Mirtazapine was then initiated for residual depressive symptoms."2.71Migraine headache prophylaxis and treatment with low-dose mirtazapine. ( Lévy, E; Margolese, HC, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lévy, E1
Margolese, HC1

Trials

1 trial available for mirtazapine and Migraine Disorders

ArticleYear
Migraine headache prophylaxis and treatment with low-dose mirtazapine.
    International clinical psychopharmacology, 2003, Volume: 18, Issue:5

    Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Mianserin; Migraine Di

2003